The US IVD industry is already in a pivotal position to secure a significant share in the healthcare industry. The main reasons for bright prospects are prevalence of several chronic and infectious diseases, emergence of technologies in hospital laboratories, and increasing patient awareness among others. The US is currently at the forefront of diagnostic market development globally.

The study identified that the US constitutes the largest and the most advanced diagnostic market in the world. Investments worth billions of dollars are being made in research and development of various market segments including, POC, clinical chemistry, immuno-assay molecular diagnostic techniques both by public and private organizations.

The research firm anticipates this trend to remain applicable during our forecast period also owing to various supporting factors and strong market fundamentals as discussed and analyzed in the report.

Further, the US IVD market is highly regulated and the top-ten IVD manufacturers presently control about 80 percent of the industry sales. However, companies do not compete in every market segment and thus, market is well poised to witness entry of new players and expansion of existing ones.

Further, despite the US recognition as the most advanced market, the competition level in various products/therapeutic categories is still not stiff and considerable business opportunities are available for market players.

Have your say and discuss with your peers on the InfoGrok community.

Participate by posting your comments now.